lencana Anda Rentang 52M $3–$19 1% of range Peringkat Analis BUY 19 analysts Target Harga $26 +697% upside P/E -0.9 ROE -148.7% Margin Laba Bersih -10998.7%

EYPT Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu

03
Harga $3.25
Kapitalisasi Pasar (MRQ) $276M
P/E (TTM) -0.9
EPS (TTM) $-3.75
Pendapatan (TTM) $3M
ROE (TTM) -148.7%
Rentang 52M $3–$19

EYPT Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda

04
rentang
batang

Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.

Pemecahan saham 2
Tanggal ex-dividen Pemecahan Tipe
9 Des. 2020 1-for-10 Terbalik
11 Juni 2008 1-for-4 Terbalik

Tentang EyePoint, Inc. - Common Stock Tinjauan perusahaan dari Wikipedia

05 · wikidata

EyePoint Pharmaceuticals Inc. (formerly pSivida Corporation) is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery.

pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency (DERA, now QinetiQ). QinetiQ continues to be a strategic partner.

In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc.

Sumber: Wikipedia (English), CC BY-SA 4.0 · Lihat di Wikipedia ↗

Wikidata ↗

sektorHealthcare industriPharmaceuticals karyawan214 negaraUS

Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS

06
Pendapatan$31M
2017-06-30 → 2025-12-31
EPS$-3.17
2017-06-30 → 2025-12-31
Arus Kas Bebas$-243M
2019-12-31 → 2025-12-31
Margin bersih-10998.7%
2019-12-31 → 2025-12-31
Valuasi & Rasio 07–12

Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?

Metrik Tren 5 Tahun EYPT rata-rata 5T Median Rekan Kesimpulan
P/E (TTM) -0.9rata-rata 5T ≈-5.8 ≈-5.8 · ·
P/S (TTM) 99.1rata-rata 5T ≈19.7 ≈19.7 56.0 Terlalu mahal
P/B (MRQ) 1.7rata-rata 5T ≈2.8 ≈2.8 1.6 Terlalu mahal
Harga / FCF (TTM) -1.0rata-rata 5T ≈-145.0 ≈-145.0 · ·
Harga / Arus Kas (TTM) -1.0rata-rata 5T ≈116.8 ≈116.8 · ·
Price / Tangible Book (Harga / Nilai Buku Berwujud) 0.9rata-rata 5T ≈2.9 ≈2.9 · ·

Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.

nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median

Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya

14
Kejutan Rata-rata -7.8%
Laporan Berikutnya Nov 03, 2026
PeriodeLaporanEPS AktualEPS EstimasiKejutan
30 Juni 2026 Agu 4, 2026 $-1.09 $-0.97 -12.3%
31 Maret 2026 $-0.99 $-0.82 -20.1%
31 Des. 2025 $-0.81 $-0.76 -6.2%
30 Sep. 2025 $-0.85 $-0.80 -6.2%
30 Juni 2025 $-0.85 $-0.81 -4.6%
31 Maret 2025 $-0.65 $-0.67 2.8%

Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas

15
Laporan Laba Rugi 16
Metrik Tren 20252024202320222021202020192018201720162015
Revenue $31M$43M$46M$41M$37M$34M$20M$5M$8M$2M$27M
R&D Expense $221M$133M$65M$50M$28M$17M$15M$19M$15M$14M$12M
SG&A Expense $52M$52M$40M$35M$26M$21M$18M$15M$11M$9M$8M
Operating Expenses $275M$189M$121M$141M$92M$72M$68M$44M$26M$23M$20M
Operating Income $-243M$-146M$-75M$-100M$-55M$-37M$-48M$-39M$-19M$-22M$6M
Interest Expense ··$1M$3M$5M$7M$6M$2M$0$0·
Interest Income ··········$19.0K
Other Non-op $12M$15M$7M$2M$292.0K$58.0K$1M$420.0K$91.0K$72.0K$22.0K
Pretax Income $-232M$-131M$-71M$-102M$-58M$-45M$-57M·$-18M$-22M$6M
Income Tax $279.0K$90.0K$83.0K·$0$0$0·$0$-155.0K$96.0K
Net Income $-232M$-131M$-71M$-102M$-58M$-45M$-57M$-86M$-18M$-22M$6M
EPS (Basic) $-3.17$-2.32$-1.82$-2.74$-2.03···$-0.52$-0.68$0.22
EPS (Diluted) $-3.17$-2.32$-1.82$-2.74$-2.03···$-0.52$-0.68$0.21
Shares (Basic) 73,25156,29838,90437,317,00028,758,000···35,343,76531,623,47329,378,250
Shares (Diluted) 73,25156,29838,90437,317,00028,758,000···35,343,76531,623,47330,584,140
EBITDA $-241M$-146M$-75M$-100M$-55M·$-48M··$-22M$6M
Neraca 27
Metrik Tren 20252024202320222021202020192018201720162015
Cash & Equivalents $102M$100M$281M$96M$179M$45M$22M$45M$17M$15M$19M
Short-term Investments $204M$271M$50M$49M$33M$0$0$0$0$14M$9M
Inventory $2M$2M$4M$3M$4M$5M$2M$279.0K···
Prepaid Expense $20M$9M$9M$10M$4M$3M$6M$1M$591.0K$483.0K$681.0K
Other Current Assets $2M$1M$1M$782.0K$517.0K······
Current Assets $329M$383M$345M$173M$238M$63M$42M$48M$18M$30M$30M
PP&E (Net) $9M$8M$5M$1M$476.0K$630.0K$357.0K$288.0K$313.0K$290.0K$338.0K
PP&E (Gross) $15M$12M$8M$3M$2M$2M$1M$983.0K$799.0K$2M$2M
Accum. Depreciation $6M$4M$3M$2M$1M$1M$839.0K$695.0K$486.0K$2M$2M
Intangibles ···$0$23M$25M$28M$30M$364.0K$1M$2M
Other Non-current Assets $6M$6M$0········
Total Assets $364M$418M$355M$180M$263M$92M$73M$78M$19M$32M$32M
Accounts Payable $10M$12M$7M$6M$7M$5M$4M$3M$1M$1M$744.0K
Accrued Liabilities $24M$18M$18M$16M$14M$8M$7M$4M$4M$4M$3M
Short-term Debt ··$0$10M$0······
Current Liabilities $37M$49M$63M$35M$24M$15M$12M$21M$5M$5M$3M
Capital Leases $21M$22M$5M$6M$2M$2M$3M$0···
Other Non-current Liabilities $87.0K$205.0K$0$600.0K$2M$2M$3M$1M$51.0K··
Total Liabilities $58M$82M$89M$84M$79M$73M$65M$41M$5M$11M$9M
Long-term Debt ···$30M·······
Total Debt ··$0$40M$37M·$47M····
Common Stock $83.0K$68.0K$49.0K$34.0K$34.0K$18.0K$11.0K$95.0K$39.0K$34.0K$29.0K
Retained Earnings $-1.10B$-873M$-742M$-671M$-569M$-511M$-465M$-408M$-311M$-292M$-271M
AOCI $961.0K$1M$864.0K$786.0K$841.0K$841.0K$840.0K$839.0K$833.0K$852.0K$945.0K
Stockholders' Equity $306M$337M$266M$96M$184M$19M$8M$38M$13M$21M$23M
Liabilities + Equity $364M$418M$355M$180M$263M$92M$73M$78M$19M$32M$32M
Shares Outstanding 82,826,41668,266,00549,043,07434,082,93433,905,82618,139,98110,941,65995,372,23639,356,99934,172,91929,412,365
Arus Kas 18
Metrik Tren 20252024202320222021202020192018201720162015
D&A $2M$2M$464.0K········
Stock-based Comp $28M$37M$12M$14M$7M$6M$5M·$2M$2M$2M
Deferred Tax $279.0K$90.0K$83.0K········
Amort. of Intangibles ··$0$2M$2M$2M$2M$981.0K$724.0K$756.0K$770.0K
Restructuring ·····$590.0K··$472.0K··
Other Non-cash $-39M··········
Operating Cash Flow $-240M$-126M$2M$-65M$-50M$-14M$-57M·$-20M$-16M$10M
CapEx $3M$4M$3M$2M$156.0K$362.0K$213.0K·$147.0K$113.0K$161.0K
Investing Cash Flow $69M$-219M$-3M$-17M$-33M$-362.0K$-213.0K·$14M$-4M·
Debt Issued ··$0$30M$0·$50M·$0$0·
Net Debt Issued ·$0$-30M$-8M$0·$30M····
Stock Issued $173M$163M$226M$0·$50M$23M·$8M$16M$0
Net Stock Activity $173M$163M$226M···$23M··$16M·
Financing Cash Flow $174M$164M$187M$-690.0K$217M$37M$34M·$9M$17M·
Net Change in Cash $2M$-182M$186M$-83M$134M$23M$-23M·$2M$-4M$4M
Taxes Paid $200.0K$100.0K·········
Free Cash Flow $-243M$-130M$-2M$-67M$-50M·$-57M··$-16M$10M
Levered FCF ··$-3M$-70M$-56M·$-63M····
Profitabilitas 7
Metrik Tren 20252024202320222021202020192018201720162015
Operating Margin -776.0%-337.1%-163.1%-240.6%-149.6%·-235.0%··-1344.1%24.2%
Net Margin -739.4%-302.4%-153.8%-247.0%-158.1%·-278.9%··-1330.1%23.9%
Pretax Margin -738.5%-302.2%-153.7%-247.0%-158.1%·-278.9%··-1339.6%24.2%
EBITDA Margin -768.6%-337.1%-163.1%-240.6%-149.6%·-235.0%··-1344.1%24.2%
ROA -59.3%-33.8%-26.4%-46.1%-32.9%·-75.1%··-67.3%23.1%
ROE -84.0%-47.1%-43.6%-87.9%-42.2%·-468.1%··-90.8%24.8%
ROIC -79.6%-43.4%-28.2%-73.2%-25.0%·-86.2%··-103.5%27.1%
Likuiditas & Solvabilitas 5
Metrik Tren 20252024202320222021202020192018201720162015
Current Ratio 8.97.85.55.010.0·3.6··5.98.9
Quick Ratio 8.37.65.24.28.9·1.9··5.78.5
Debt / Equity ··0.00.40.2·5.7····
LT Debt / Equity ···0.30.2·5.7····
Interest Coverage ··-60.2-31.2-10.1·-7.7····
Efisiensi 1
Metrik Tren 20252024202320222021202020192018201720162015
Asset Turnover 0.10.10.20.20.2·0.3··0.11.0
Per Saham 5
Metrik Tren 20252024202320222021202020192018201720162015
Book Value / Share $3.70$4.93$5.43$2.83$5.44·$0.08··$0.61$0.79
Revenue / Share $428.27$768.64$1.18$1.11·····$0.05$0.87
Cash Flow / Share $-3277.91$-2242.10$0.05$-1.74·····$-0.52$0.34
Cash / Share $1.23$1.46$5.74$2.81$5.27·$0.20··$0.45$0.65
EPS (TTM) $-3.17$-2.32$-1.82$-2.74$-2.03$-0.67$-0.67·$-0.52$-0.68$0.21
Tingkat Pertumbuhan 3
Metrik Tren 20252024202320222021202020192018201720162015
Revenue YoY -27.5%-6.0%11.1%12.1%7.3%······
Revenue CAGR 3Y -8.8%5.4%10.2%········
Revenue CAGR 5Y -1.8%··········
Valuasi (TTM) 14
Metrik Tren 20252024202320222021202020192018201720162015
Revenue TTM $31M$43M$46M$41M$37M$34M$20M·$8M$2M$27M
Net Income TTM $-232M$-131M$-71M$-102M$-58M$-45M$-57M·$-18M$-22M$6M
Market Cap $1.51B$509M$1.13B$119M$415M·$1.70B··$967M$1.11B
Enterprise Value ··$802M$15M$240M·$1.72B····
P/E -5.8-3.2-12.7-1.3-6.0-9.8-23.1·-32.9-41.6179.5
P/S 48.211.824.62.911.2·83.3··597.041.7
P/B 4.91.54.31.22.3·203.6··46.347.5
P / Tangible Book 4.91.54.31.22.6······
P / Cash Flow -6.3-4.0604.5-1.8-8.3·-29.9··-59.3107.7
P / FCF -6.2-3.9-704.8-1.8-8.3·-29.8··-58.9109.4
EV / EBITDA ··-10.7-0.1-4.3·-36.0····
EV / FCF ··-499.0-0.2-4.8·-30.2····
EV / Revenue ··17.40.46.5·84.5····
Earnings Yield -17.3%-31.1%-7.9%-78.3%-16.6%-10.2%-4.3%·-3.0%-2.4%0.56%

Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·

Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir

16
Metrik 2025-12-312024-12-312023-12-312022-12-312021-12-31
Pendapatan $31M $43M $46M $41M $37M
Margin Operasi % -776.0% -337.1% -163.1% -240.6% -149.6%
Laba Bersih $-232M $-131M $-71M $-102M $-58M
EPS Dilusian $-3.17 $-2.32 $-1.82 $-2.74 $-2.03

Pemilik institusional (13F) 214 pengaju · $1.5B total · Per tanggal 30 Sep. 2026

17

Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.

Pemegang 214
Nilai yang dipegang $1.5B
Posisi baru 29
Posisi yang keluar 21
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
Posisi baru Posisi yang keluar Meningkat Menurun Perubahan bersih saham
29 (-33 vs Kuartal sebelumnya) 21 (-2 vs Kuartal sebelumnya) 66 (-10 vs Kuartal sebelumnya) 60 (+22 vs Kuartal sebelumnya) +2.4M

Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.

Institusi Nilai Saham % dari 13F yang dilacak Tipe
MONTANOVA CAPITAL, LLC $118.638.163 8.296.375 8,06% Saham
BlackRock, Inc. $106.723.718 7.463.197 7,25% Saham
Cormorant Asset Management, LP $100.100.000 7.000.000 6,80% Saham
VANGUARD GROUP INC $88.100.480 4.822.139 5,99% Saham
FEDERATED HERMES, INC. $81.239.044 5.681.052 5,52% Saham
ADAGE CAPITAL PARTNERS GP, L.L.C. $69.037.426 4.827.792 4,69% Saham
FRANKLIN RESOURCES INC $68.741.215 4.807.078 4,67% Saham
Commodore Capital LP $65.780.000 4.600.000 4,47% Saham
VANGUARD CAPITAL MANAGEMENT LLC $51.912.604 3.630.252 3,53% Saham
JANUS HENDERSON GROUP PLC $46.419.056 3.601.168 3,15% Saham
Paradigm Biocapital Advisors LP $41.332.677 2.890.397 2,81% Saham
STATE STREET CORP $33.712.894 2.357.545 2,29% Saham
GEODE CAPITAL MANAGEMENT, LLC $29.497.382 2.062.390 2,00% Saham
Aberdeen Group plc $28.725.869 2.008.802 1,95% Saham
PERCEPTIVE ADVISORS LLC $28.600.000 2.000.000 1,94% Opsi jual
CITADEL ADVISORS LLC $28.279.823 1.977.610 1,92% Saham
Balyasny Asset Management L.P. $25.916.719 1.812.358 1,76% Saham
Parkman Healthcare Partners LLC $18.420.731 1.288.163 1,25% Saham
EVENTIDE ASSET MANAGEMENT, LLC $17.811.837 1.245.583 1,21% Saham
TWO SIGMA INVESTMENTS, LP $16.890.345 1.181.143 1,15% Saham
Essex Woodlands Management, Inc. $15.513.455 1.084.857 1,05% Saham
ORBIMED ADVISORS LLC $15.288.802 1.069.147 1,04% Saham
5AM Venture Management, LLC $15.015.000 1.050.000 1,02% Saham
Rosalind Advisors, Inc. $14.131.689 988.230 0,96% Saham
VANGUARD PORTFOLIO MANAGEMENT LLC $13.885.500 971.014 0,94% Saham
AMERIPRISE FINANCIAL INC $12.132.298 848.410 0,82% Saham
DIMENSIONAL FUND ADVISORS LP $12.035.896 841.746 0,82% Saham
HSBC HOLDINGS PLC $11.918.407 833.455 0,81% Saham
Candriam S.C.A. $11.254.258 787.769 0,76% Saham
Artia Global Partners LP $10.969.501 767.098 0,75% Saham
Blue Owl Capital Holdings LP $10.905.094 762.594 0,74% Saham
NORTHERN TRUST CORP $10.309.113 720.917 0,70% Saham
Patient Square Capital LP $10.296.000 720.000 0,70% Saham
Principia Wealth Advisory, LLC $9.293.530 649.944 0,63% Saham
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $9.260.866 647.613 0,63% Saham
Sio Capital Management, LLC $8.910.759 623.130 0,61% Saham
VANGUARD FIDUCIARY TRUST CO $7.996.789 559.216 0,54% Saham
SUSQUEHANNA INTERNATIONAL GROUP, LLP $7.899.320 552.400 0,54% Opsi beli
Alyeska Investment Group, L.P. $7.284.463 509.403 0,50% Saham
MILLENNIUM MANAGEMENT LLC $7.151.330 500.093 0,49% Saham
GOLDMAN SACHS GROUP INC $6.650.744 465.087 0,45% Saham
Simplify Asset Management Inc. $5.720.629 400.044 0,39% Saham
Ikarian Capital, LLC $5.296.720 370.400 0,36% Opsi beli
Ikarian Capital, LLC $5.296.720 370.400 0,36% Opsi jual
Ghisallo Capital Management LLC $5.005.000 350.000 0,34% Saham
STEMPOINT CAPITAL LP $4.840.135 338.471 0,33% Saham
MORGAN STANLEY $4.815.240 336.730 0,33% Saham
E Fund Management Co., Ltd. $4.730.068 330.774 0,32% Saham
Jump Financial, LLC $4.586.825 320.757 0,31% Saham
Bleichroeder LP $4.526.165 316.515 0,31% Saham

Tampilkan semua 214 pemilik institusional →

Aktivis & pemilik 5%+ 5 saham

18

Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.

Pengaju Diajukan Kepemilikan Status Tujuan Pengajuan
EW Healthcare Partners L.P., EW Healthcare Partners-A L.P., Essex Woodlands Fund IX-GP, L.P., Essex Woodlands IX, LLC, Martin P. Sutter, R. Scott Barry, Ronald Eastman, Petri Vainio, Steve Wiggins ×4 pengajuan 8 Des. 2023 · Pengajuan awal · SEC
Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan 30 Agu 2023 · Pengajuan awal · SEC
Ocumension Therapeutics 22 Jan. 2021 · Pengajuan awal · SEC
IRS Identification Nos. of above persons (entities only) Pfizer Inc. ×2 pengajuan 26 Mei 2017 · Pengajuan awal · SEC
Pfizer Inc. 17 Juli 2007 · Pengajuan awal · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Orang dalam perusahaan 34 orang dalam · 14 pejabat · 22 direktur

19
Orang Dalam Peran Aktivitas terakhir Saham dimiliki Beli 12m Jual 12m Bersih 12m
Jay S. Duker President and CEO 10 Juli 2026 M 9.594 1 0 $19.725
Paul Ashton President & CEO 18 Maret 2016 M 450.741 0 0 $0
George Elston Chief Financial Officer 20 Agu 2026 G 64.953 0 0 $0
David Price CFO 25 Juni 2019 A · 0 0 $0
Michael Soja VP Finance, CFO & Treasurer 10 Sep. 2008 A · 0 0 $0
Ramiro Ribeiro Chief Medical Officer 30 Juni 2026 M 0 0 7 $-948.955
Dario A. Paggiarino Chief Medical Officer 30 Maret 2024 M 67.080 0 0 $0
David Scott Jones SVP & Chief Commercial Officer 9 Feb. 2024 M 44.916 0 0 $0
Michael Craig Pine Chief Corp Dev.&Strat. Officer 6 Jan. 2024 M 13.662 0 0 $0
Leonard S Ross VP Finance and Chief Accounting Officer 27 Juni 2019 M 90.044 0 0 $0
Leonard M Blum Executive VP and General Manager, US 14 Mei 2018 A · 0 0 $0
Debora Jorn EVP, Corp. & Comm'l Dev. 27 Juni 2017 A · 0 0 $0
Lori Freedman VP Corporate Affairs, General Counsel and Secretary 21 Juli 2016 A 96.423 0 0 $0
Aaron Finlay Secretary 18 Okt. 2007 A · 0 0 $0
Karen L. Zaderej Direktur 18 Agu 2026 P 49.100 1 0 $52.258
Nancy Lurker Direktur 6 Jan. 2026 M 294.346 0 3 $-150.988
Reginald J. Sanders Direktur 2 Jan. 2026 A · 0 0 $0
Stuart Duty Direktur 2 Jan. 2026 A · 0 0 $0
John B. Landis Direktur 2 Jan. 2026 A 21.400 0 0 $0
Wendy F Dicicco Direktur 2 Jan. 2026 A 9.967 0 0 $0
ANDO GORAN Direktur 2 Jan. 2026 A 13.150 0 0 $0
Fred Hassan Direktur 2 Jan. 2026 A · 0 0 $0
David R Guyer Direktur 12 Juli 2024 M 1.850 0 0 $0
Anthony P Adamis Direktur 23 Juni 2024 M 4.000 0 0 $0
Ye Liu Direktur 11 Jan. 2024 S 100.221 0 0 $0
OcuMension Therapeutics Direktur 11 Jan. 2024 S 100.221 0 0 $0
Douglas Evan Godshall Direktur 22 Juni 2021 A 8.016 0 0 $0
Kristine Peterson Direktur 28 Feb. 2020 A 6.667 0 0 $0
David J Mazzo Direktur 9 Okt. 2019 M 200.083 0 0 $0
Michael W Rogers Direktur 25 Juni 2019 A 119.167 0 0 $0
James J Barry Direktur 7 Mei 2018 M 12.500 0 0 $0
SAVAS PETER G Direktur 3 Des. 2015 A · 0 0 $0
Paul Hopper Direktur 18 Des. 2013 A 10.000 0 0 $0
Katherine Woodthorpe Direktur 27 Nov. 2007 A · 0 0 $0

Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka

Kepemilikan ETF Dimiliki oleh 30 ETF

20

Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.

Dana Bobot Unit Per tanggal Sumber
PILL · Direxion Shares ETF Trust 1,13% 19.051 NS 31 Juli 2026 N-PORT
BBC · ETFis Series Trust I 0,63% 23.853 NS 31 Juli 2026 N-PORT
QQQS · Invesco Exchange-Traded Fund Trust … 0,38% 26.636 SH 1 Okt. 2026 Harian
IWC · iShares Trust 0,08% 263.363 SH 11 Sep. 2026 Harian
IHE · iShares Trust 0,08% 290.098 SH 11 Sep. 2026 Harian
VFMO · VANGUARD WELLINGTON FUND 0,06% 86.797 SH 19 Agu 2026 Harian
VTWG · VANGUARD SCOTTSDALE FUNDS 0,05% 69.310 SH 19 Agu 2026 Harian
RSSL · Global X Funds 0,03% 36.951 NS 31 Juli 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0,03% 445.218 SH 19 Agu 2026 Harian
IBBQ · Invesco Exchange-Traded Fund Trust … 0,02% 5.967 SH 1 Okt. 2026 Harian
IWO · iShares Trust 0,02% 607.108 SH 11 Sep. 2026 Harian
DFAS · Dimensional ETF Trust 0,02% 207.955 NS 31 Juli 2026 N-PORT
FHLC · FIDELITY COVINGTON TRUST 0,01% 35.128 NS 31 Juli 2026 N-PORT
IWM · iShares Trust 0,01% 1.984.162 SH 11 Sep. 2026 Harian
VXF · VANGUARD INDEX FUNDS 0,01% 901.417 SH 19 Agu 2026 Harian
VTWV · VANGUARD SCOTTSDALE FUNDS 0,01% 11.210 SH 19 Agu 2026 Harian
VHT · VANGUARD WORLD FUND 0,01% 213.549 SH 19 Agu 2026 Harian
PRFZ · Invesco Exchange-Traded Fund Trust 0,01% 61.492 SH 1 Okt. 2026 Harian
WSML · iShares Trust 0,00% 4.573 SH 11 Sep. 2026 Harian
DCOR · Dimensional ETF Trust 0,00% 5.922 NS 31 Juli 2026 N-PORT
DFAC · Dimensional ETF Trust 0,00% 48.608 NS 31 Juli 2026 N-PORT
DFAU · Dimensional ETF Trust 0,00% 10.667 NS 31 Juli 2026 N-PORT
DFUS · Dimensional ETF Trust 0,00% 16.256 NS 31 Juli 2026 N-PORT
ITOT · iShares Trust 0,00% 111.657 SH 11 Sep. 2026 Harian
IWV · iShares Trust 0,00% 22.216 SH 3 Sep. 2026 Harian
VTI · VANGUARD INDEX FUNDS 0,00% 2.643.860 SH 19 Agu 2026 Harian
VTHR · VANGUARD SCOTTSDALE FUNDS 0,00% 6.035 SH 19 Agu 2026 Harian
IWN · iShares Trust · 121.398 SH 11 Sep. 2026 Harian
ISCB · iShares Trust · 3.155 SH 11 Sep. 2026 Harian
ISCV · iShares Trust · 15.627 SH 11 Sep. 2026 Harian

EYPT Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan

21
peringkat · 19 analis BELI
Target median $20.00 +515,4%
6 31,6% Beli Kuat
7 36,8% Beli
6 31,6% Tahan
0 0,0% Jual
0 0,0% Jual Kuat

Target Harga 12 Bulan

11 analis · 2026-09-30

Target rata-rata $25.91 +697,2%

← Di bawah semua target Harga saat ini $3.25
Rendah$4.00 Rata-rata$25.91 Tinggi$68.00

Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor

22

Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.

Ticker Kapitalisasi Pasar P/E Pendapatan YoY Margin Bersih ROE Margin Kotor
EYPT $1.51B -5.8 -27.5% -739.4% -84.0% ·
BIOA $495M -5.9 · -896.1% -28.4% ·
FULC $753M -9.6 2752.0% · -26.6% ·
SIGA $438M 19.1 -31.8% 24.6% 11.4% ·
ANTX $31M -1.0 · · -57.7% ·
ORMP $112M 1.9 -50.4% 3202.5% 37.0% 0.65%
LLY · 46.8 44.7% 31.7% 101.2% ·

Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap

26

Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.

Pilihan Anda disimpan dan mengikuti Anda di semua ticker.

Sumber: SEC 10-Q diajukan Agu 5, 2026